AAAAAA

   
Results: 1-10 |
Results: 10
RECOMBINANT INTERLEUKIN-6 IN THE TREATMENT OF CONGENITAL THROMBOCYTOPENIA ASSOCIATED WITH ABSENT RADII
Authors: AQUINO VM MUSTAFA MM VAICKUS L WOOLEY R BUCHANAN GR
Citation: Vm. Aquino et al., RECOMBINANT INTERLEUKIN-6 IN THE TREATMENT OF CONGENITAL THROMBOCYTOPENIA ASSOCIATED WITH ABSENT RADII, Journal of pediatric hematology/oncology, 20(5), 1998, pp. 474-476
RECOMBINANT HUMAN INTERFERON-BETA (RHUIFN-BETA) AND RADIATION-THERAPYFOR INOPERABLE NONSMALL CELL LUNG-CANCER
Authors: BYHARDT RW VAICKUS L WITT PL CHANG AY MCAULIFFE T WILSON JF LAWTON CA BREITMEYER J ALGER ME BORDEN EC
Citation: Rw. Byhardt et al., RECOMBINANT HUMAN INTERFERON-BETA (RHUIFN-BETA) AND RADIATION-THERAPYFOR INOPERABLE NONSMALL CELL LUNG-CANCER, Journal of interferon & cytokine research, 16(11), 1996, pp. 891-902
DAILY SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 EXPANDS NATURAL-KILLER-CELLS IN-VIVO WITHOUT SIGNIFICANT TOXICITY
Authors: MEROPOL NJ PORTER M BLUMENSON LE LINDEMANN MJ PEREZ RP VAICKUS L LOEWEN GM CREAVEN PJ WILKES KA GIEDLIN MA CALIGIURI MA
Citation: Nj. Meropol et al., DAILY SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 EXPANDS NATURAL-KILLER-CELLS IN-VIVO WITHOUT SIGNIFICANT TOXICITY, Clinical cancer research, 2(4), 1996, pp. 669-677
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY
Authors: MEROPOL NJ PETRELLI NJ LIPMAN BJ RODRIGUEZBIGAS M HICKS W DOUGLASS HO SMITH JL RASEY M BLUMENSON LE VAICKUS L HAYES FA AGOSTI JM
Citation: Nj. Meropol et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY, The American journal of surgery, 172(3), 1996, pp. 299-302
IMMUNE-RESPONSES IN PATIENTS WITH T-CELL LYMPHOMA TREATED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING A HIGHLY RESTRICTED T-CELL ANTIGEN
Authors: FOON KA OSEROFF AR VAICKUS L GREENBERG SJ RUSSELL D BERNSTEIN Z PINCUS S KOHLER H SEON BK TAHAOGLU E BEERS T CHAKRABORTY M BHATACHARYACHATTERJEE M
Citation: Ka. Foon et al., IMMUNE-RESPONSES IN PATIENTS WITH T-CELL LYMPHOMA TREATED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING A HIGHLY RESTRICTED T-CELL ANTIGEN, Clinical cancer research, 1(11), 1995, pp. 1285-1294
PLATELET TRANSFUSION AND ALTERNATIVES TO TRANSFUSION IN PATIENTS WITHMALIGNANCY
Authors: VAICKUS L BREITMEYER JB SCHLOSSMAN RL ANDERSON KC
Citation: L. Vaickus et al., PLATELET TRANSFUSION AND ALTERNATIVES TO TRANSFUSION IN PATIENTS WITHMALIGNANCY, Stem cells, 13(6), 1995, pp. 588-596
MODULATION OF VEGF AND EGFR EXPRESSION BY RECOMBINANT IFN-BETA AND DEXAMETHASONE IN HUMAN GLIOMA-CELLS
Authors: HONG YK STECK PA VAICKUS L YUNG WKA
Citation: Yk. Hong et al., MODULATION OF VEGF AND EGFR EXPRESSION BY RECOMBINANT IFN-BETA AND DEXAMETHASONE IN HUMAN GLIOMA-CELLS, Neurology, 45(4), 1995, pp. 450-450
MALIGNANCY-RELATED PERICARDIAL-EFFUSION - 127 CASES FROM THE ROSWELL-PARK-CANCER-INSTITUTE
Authors: WILKES JD FIDIAS P VAICKUS L PEREZ RP
Citation: Jd. Wilkes et al., MALIGNANCY-RELATED PERICARDIAL-EFFUSION - 127 CASES FROM THE ROSWELL-PARK-CANCER-INSTITUTE, Cancer, 76(8), 1995, pp. 1377-1387
CARBOPLATIN FOR SMALL-CELL LUNG-CANCER - PROGRESS TOWARD GREATER EFFICACY AND REDUCED TOXICITY
Authors: RAGHAVAN D PEREZ R CREAVEN P TAKITA H LOEWEN G VAICKUS L
Citation: D. Raghavan et al., CARBOPLATIN FOR SMALL-CELL LUNG-CANCER - PROGRESS TOWARD GREATER EFFICACY AND REDUCED TOXICITY, Seminars in oncology, 21(3), 1994, pp. 1-8
ACUTE PROGRANULOCYTIC LEUKEMIA (APL) - POSSIBLE IN-VIVO DIFFERENTIATION BY GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
Authors: VAICKUS L VILLALONACALERO MA CALIGIURI T
Citation: L. Vaickus et al., ACUTE PROGRANULOCYTIC LEUKEMIA (APL) - POSSIBLE IN-VIVO DIFFERENTIATION BY GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), Leukemia, 7(10), 1993, pp. 1680-1681
Risultati: 1-10 |